Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5 (Q9864)

From Wikibase.slis.ua.edu
Revision as of 13:55, 22 May 2020 by Admin (talk | contribs) (‎Created claim: Property:P154: Przepiorka Donna, #quickstatements; #temporary_batch_1590155687727)
Jump to navigation Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Norsworthy Kelly J., et al. Clinical Cancer Research (2019) cited as Ref 601 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    First Author string
    Norsworthy Kelly J.
    0 references
    Second Author string
    By Kunthel
    0 references
    Third Author string
    Subramaniam Sriram
    0 references
    Issue
    20
    0 references
    PubMed ID
    31064779
    0 references
    Publication Date
    2019
    0 references
    Published In Name String
    Clinical Cancer Research
    0 references
    Volume
    25
    0 references
    title
    FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia (English)
    0 references
    Page(s)
    6021-6025
    0 references
    Fourth Author string
    Zhuang Luning
    0 references
    Fifth Author string
    Del Valle Pedro L.
    0 references
    Sixth Author string
    Przepiorka Donna
    0 references
     

    Sitelinks

    Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q9864&oldid=207756"